Electromedical Technologies Inc Revenue Growth Rates (EMED), Current and Historic Growth - CSIMarket
CSIMarket
 


Electromedical Technologies Inc   (EMED)
 

EMED's Revenue Growth by Quarter and Year

Electromedical Technologies Inc 's Revenue results by quarter and year




EMED Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
4th Quarter December -
3rd Quarter September -0.30
2nd Quarter June 0.24
1st Quarter March 0.29
FY 0.23





EMED Revenue third quarter 2024 Y/Y Growth Comment
Electromedical Technologies Inc in the third quarter 2024 recorded of $ -0.30 millions.

According to the results reported in the third quarter 2024, Electromedical Technologies Inc achieved the best Revenue growth in Medical Equipment & Supplies industry. While Electromedical Technologies Inc ' s Revenue meltdown of -192.55% ranks overall at the positon no. in the third quarter 2024.




EMED Revenue ( Y/Y Growth %) 2024
2023 2022 2021
4th Quarter December - -16.67 % 75 % 33.33 %
3rd Quarter September - 14.29 % -6.67 % 42.86 %
2nd Quarter June -17.24 % 26.09 % 15 % 42.86 %
1st Quarter March -23.68 % 72.73 % 29.41 % -19.05 %
FY   - 16.52 % 26.37 % -

Financial Statements
Electromedical Technologies Inc 's third quarter 2024 Revenue $ -0.30 millions EMED's Income Statement
Electromedical Technologies Inc 's third quarter 2023 Revenue $ 0.32 millions Quarterly EMED's Income Statement


EMED Revenue (Quarter on Quarter Growth %)

2024
2023 2022 2021
4th Quarter December - 9.37 % 50 % -20 %
3rd Quarter September - 10.34 % 21.74 % 50 %
2nd Quarter June -17.24 % -23.68 % 4.55 % 17.65 %
1st Quarter March -17.14 % -9.52 % -8.33 % -5.56 %
FY (Year on Year)   - 16.52 % 26.37 % -




Revenue third quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue third quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Electromedical Technologies Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


EMED's III. Quarter Q/Q Revenue Comment
Recent accomplishment of -0.30 millions by Electromedical Technologies Inc come out even worse considering the 0.24 millions a quarter before.

Within Medical Equipment & Supplies industry Electromedical Technologies Inc achieved highest sequential Revenue growth. While Electromedical Technologies Inc 's Revenue growth quarter on quarter, overall rank is .


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


EMED's III. Quarter Q/Q Revenue Comment
Recent accomplishment of -0.30 millions by Electromedical Technologies Inc come out even worse considering the 0.24 millions a quarter before.

Within Medical Equipment & Supplies industry Electromedical Technologies Inc achieved highest sequential Revenue growth. While Electromedical Technologies Inc 's Revenue growth quarter on quarter, overall rank is .


Electromedical Technologies Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2024)
12 Months Ending
(Jun 30 2024)
12 Months Ending
(Mar 31 2024)
12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
Cumulative Revenue 12 Months Ending $ 0.58 $ 1.20 $ 1.26 $ 1.35 $ 1.42
Y / Y Revenue Growth (TTM) -58.93 % -12.58 % -3.53 % 17.3 % 47.41 %
Year on Year Revenue Growth Overall Ranking # 291 # 0 # 0 # 0 # 0
Seqeuential Revenue Change (TTM) -51.52 % -4.55 % -6.55 % -5.04 % 3.2 %
Seq. Revenue Growth (TTM) Overall Ranking # 2480 # 2323 # 0 # 0 # 0


Cumulative Revenue growth Comment
Electromedical Technologies Inc 's cumulative 12 months Revenue continue to drop, but on the faster rate at -58.93% year on year, at Sep 30 2024 compare to the -12.58% decrease at Jun 30 2024. If the Electromedical Technologies Inc 's fiscal year would end at Sep 30 2024, annual Revenue would be $1 millions.

In the Healthcare sector 96 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 291.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 128
Healthcare Sector # 97
Overall # 291

Revenue TTM Y/Y Growth Statistics
High Average Low
47.41 %
8.68 %
-58.93 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 128
Sector # 394
S&P 500 # 2480
Cumulative Revenue growth Comment
Electromedical Technologies Inc 's cumulative 12 months Revenue continue to drop, but on the faster rate at -58.93% year on year, at Sep 30 2024 compare to the -12.58% decrease at Jun 30 2024. If the Electromedical Technologies Inc 's fiscal year would end at Sep 30 2024, annual Revenue would be $1 millions.

In the Healthcare sector 96 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 291.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 128
Healthcare Sector # 97
Overall # 291

Revenue TTM Y/Y Growth Statistics
High Average Low
47.41 %
8.68 %
-58.93 %
 






Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
EMED's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue drop for the quarter ending Sep 30 2024 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2024
West Pharmaceutical Services Inc -0.08%$ -0.080 millions
Nektar Therapeutics-0.08%$ -0.083 millions
Apyx Medical Corp-0.22%$ -0.219 millions
Avantor Inc -0.34%$ -0.337 millions
Avanos Medical Inc -0.35%$ -0.352 millions
Integra Lifesciences Holdings Corp-0.41%$ -0.415 millions
Nuwellis Inc -0.59%$ -0.588 millions
Alkermes Plc -0.73%$ -0.734 millions
Prestige Consumer Healthcare Inc -0.92%$ -0.922 millions
Psychemedics Corporation-1.02%$ -1.021 millions
Petros Pharmaceuticals inc -1.34%$ -1.342 millions
10x Genomics Inc -1.39%$ -1.391 millions
Abcellera Biologics Inc -1.39%$ -1.394 millions
Nephros Inc -1.41%$ -1.409 millions
Charles River Laboratories International inc -1.64%$ -1.642 millions
Inspiremd Inc -1.67%$ -1.669 millions
Cv Sciences Inc -1.69%$ -1.691 millions
Elutia Inc -1.71%$ -1.712 millions
Enhabit Inc -1.82%$ -1.820 millions
Accuray Incorporated-1.96%$ -1.956 millions
Zimvie Inc -1.98%$ -1.984 millions
Reflect Scientific Inc-2.25%$ -2.254 millions
Upstream Bio Inc -2.25%$ -2.254 millions
Maravai Lifesciences Holdings Inc -2.49%$ -2.490 millions
Biogen Inc -2.55%$ -2.549 millions
Fresenius Medical Care Ag-2.66%$ -2.658 millions
Opko Health Inc -2.78%$ -2.779 millions
Precision Optics Corporation Inc -2.87%$ -2.874 millions
Msa Safety Inc-2.98%$ -2.985 millions
Teladoc Health Inc -2.99%$ -2.988 millions


About Electromedical Technologies Inc Revenue Growth Rates (EMED), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Electromedical Technologies Inc (CIK 1715819).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001437749-24-035746
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Electromedical Technologies Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.